Taiwan Diabetes Registry

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

The Diabetes Association of the Republic of China (Taiwan)

Taipei, 10046, Taiwan

Location status: Recruiting

About this study

At the first year (2015), the patients ever enrolled into the quality control study by Taiwan Association of Diabetes Educators in 2006 and 2011 will be recruited, and their relevant clinical data will be regularly registered yearly until 2030. In addition, it is planned that type 1 diabetic patients will be enrolled, and their clinical data will be regularly recorded yearly until 2030. Also, newly diagnosed type 2 diabetic patients will be recruited, and their clinical data will be regularly entered to the diabetes web-based system yearly until 2030. We will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030. Finally, we will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of diabetes mellitus

Exclusion criteria

Patients who do not have diabetes mellitus
Participating in an interventional trial requiring informed consent

Treatment and study plan

Observational study - registry

Other

Observational study - registry

Primary outcomes

Provide data on patient characteristics

Time frame: Ten years
Provide data on disease management.

Time frame: Ten years

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

The Diabetes Association of the Republic of China (Taiwan)

Other

Registry information

Official study title

Taiwan Diabetes Registry (TDR)

Important dates

Study start: 2015
Primary completion: 2030
Study completion: 2030
First posted: Nov 22, 2023
Registry last updated: Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting